Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


QUOTED. Dec 13, 2017. Kyparissia Sirinakis.

Executive Summary

Check out what Kyparissia Sirinakis, managing partner of Epidarex Capital, had to say about misperceptions related to early-stage medtech venture investing.

"There's a bit of a misperception that the exits are not as large. There's also a little bit of a misperception that corporate buyers in the medtech space aren't going to come in very early, they're not going to pay too much, and then you're going to struggle to get reimbursement." – Kyparissia Sirinakis, managing partner, Epidarex Capital

> Find out more: Harpoon Finds Its Whale: Edwards Spends Up To $250m For Beating-Heart Mitral Repair Option

Click here for a free trial of Medtech Insight

Related Content


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts